A swollen lymph node and a positive Bartonella antibody result can fit cat scratch disease—but neither establishes the diagnosis alone. Timing, the laboratory method, and the specimen chosen for PCR can change the next step.
- Cat scratch disease test usually measures antibodies to Bartonella henselae; a single positive result cannot reliably separate past exposure from active infection.
- Antibody titers describe dilution, not bacterial count: 1:256 is four times the endpoint dilution of 1:64, but does not mean four times the illness severity.
- Bartonella henselae IgG above 1:256 supports recent or current infection in some interpretive schemes, but laboratory-specific cutoffs and symptoms still govern interpretation.
- Bartonella IgM interpretation requires caution: a negative result does not exclude cat scratch disease, particularly when testing occurs several weeks after symptoms begin.
- Repeat serology after roughly 10–21 days may clarify an early negative or borderline result; use the same laboratory and assay whenever possible.
- Fourfold titer rise means a change such as 1:128 to 1:512 and provides stronger evidence of recent infection than one isolated IgG result.
- PCR specimen choice matters: lymph-node aspirate or tissue can be more informative than peripheral blood in localized lymph-node disease, but sampling needs a clinical reason.
- Cal una valoració urgent is warranted for new vision loss, confusion, severe abdominal pain, or fever in an immunocompromised patient—do not wait 2–3 weeks for repeat antibodies.
What does a cat scratch disease test actually tell you?
A cat scratch disease test usually measures antibodies to Bartonella henselae, the bacterium associated with cat scratch disease. One positive titer cannot reliably distinguish past exposure from active infection; a compatible examination, repeat antibodies after approximately 2–3 weeks, or appropriately selected PCR may help clarify the diagnosis.
The usual clinical question is whether a new swollen lymph node belongs to the same story as recent cat exposure. A tender underarm node appearing 2 weeks after a kitten scratches the hand makes Bartonella plausible; the identical antibody result in someone without symptoms may represent an old immune response instead.
Kantesti és una Analitzador de sang amb IA that can help explain a reported Bartonella titer alongside its collection date and laboratory reference interval. Antibodies can remain detectable for months to years, so even a clearly positive result is not a stand-alone instruction to take antibiotics, as CDC clinical guidance explains.
I’m Thomas Klein, MD, and the distinction I focus on is evidence of exposure versus evidence that explains today’s symptoms. Consider 2 otherwise similar reports: one accompanies a shrinking regional node, while the other accompanies persistent fever and multiple enlarging nodes; the second patient needs a broader assessment, not simply a stronger interpretation of the same number.
A positive antibody result is a clue. Our guide to significat d'un resultat positiu d'anticossos explains why infection-specific antibodies differ from immunity tests and autoimmune markers; our organització i missió clínica also describes Kantesti’s role as an explanation service rather than a substitute for the examination that connects those clues.
When do swollen lymph nodes after cat exposure fit Bartonella?
Malaltia per gratada de gat commonly causes a localized swollen lymph node approximately 1–3 weeks after an inoculation event. A small bump at the contact site may appear earlier, but an unnoticed scratch or an absent skin mark does not rule the condition out.
Location adds more diagnostic information than many patients expect. A hand or forearm contact site can drain toward elbow or underarm nodes, whereas contact around the head may precede cervical nodes; 1 regional cluster fits typical disease better than unrelated nodes appearing simultaneously across several body regions.
Kittens and cats with fleas are common exposure clues, but owning a cat is not itself a diagnosis. Clinicians ask about scratches, bites, and licking of an affected skin site during the preceding 2–8 weeks; Bartonella transmission involves contaminated material entering skin or mucosal surfaces, not simply being near an animal.
The timeline can be misleading because the scratch often heals before the lymph node becomes obvious. In an illustrative case, a parent remembers only a kitten adopted 4 weeks earlier after being asked about household changes; that history helps select testing, but it still cannot establish which organism caused the node.
Exposure antibodies are also vulnerable to mistaken timelines in other infections. Our explanation of recent exposure versus infection uses ASO titers to illustrate the same reasoning problem: an immune marker may outlast the event that triggered it, sometimes by several months.
What do Bartonella antibody titers such as 1:64 or 1:256 mean?
Bartonella antibody titers report the highest serum dilution at which an assay still detects antibodies. A result of 1:256 represents a greater endpoint dilution than 1:64; it does not report the number of bacteria in the body or measure disease severity.
Indirect immunofluorescence assays often use doubling dilutions: 1:64, 1:128, 1:256, and 1:512. Moving from 1:64 to 1:256 crosses 2 dilution steps, producing a fourfold increase; moving from 1:128 to 1:256 crosses only 1 step and may reflect ordinary analytical variation.
The assay method is part of the result. Some laboratories use immunofluorescence, while others report an enzyme immunoassay index or arbitrary units; a value of 2.1 on an index-based assay cannot be converted into a titer of 1:256 without a validated relationship supplied by that laboratory.
A report may also list antibodies to both B. henselae and B. quintana. Cross-reactivity between Bartonella species means that 2 positive species results do not automatically establish 2 separate infections; exposure history and, when necessary, species-specific molecular testing provide information that antibody patterns alone may not.
Before comparing 2 reports, check the organism, antibody class, assay, reference interval, and collection date. Our guide to resultats qualitatius i quantitatius explains why a simple positive flag can hide useful detail—and why more decimal places do not necessarily mean more diagnostic certainty.
How should Bartonella henselae IgG results be interpreted?
Bartonella henselae IgG indicates an immune response to Bartonella antigens, not necessarily an ongoing infection. Some clinical references treat titers above 1:256 as strongly supportive in a compatible illness, but a single high IgG result can persist after recovery and must be interpreted using the reporting laboratory’s criteria.
The often-quoted 1:64 and 1:256 boundaries come from particular assays and clinical interpretive conventions, not universal biological switches. Klotz, Ianas, and Elliott’s American Family Physician review describes low titers as less supportive and higher titers as more supportive, while emphasizing the combination of exposure, lymphadenopathy, and serology (Klotz et al., 2011).
A stable IgG titer of 1:512 in someone whose node has been shrinking for 6 weeks does not prove treatment failure. The immune system clears antibody signals more slowly than symptoms may improve; repeating IgG until it becomes negative can create unnecessary appointments, expense, and pressure to extend antibiotics.
An isolated IgG of 1:128 is especially vulnerable to overinterpretation when the initial suspicion is low. A patient with no plausible exposure and a hard supraclavicular node needs investigation of that node, even if the laboratory labels the antibody positive; the test’s relevance depends on the probability of disease before testing.
IgG positivity also behaves differently across organisms. Our discussion of IgG-positive, IgM-negative patterns shows why the familiar phrase past exposure cannot be transferred mechanically to every infection, and why 1 immune pattern may support several possible timelines.
Does Bartonella IgM prove a recent infection?
Bartonella IgM can support a recent infection, but it neither reliably confirms nor excludes cat scratch disease by itself. IgM may be absent, short-lived, or nonspecifically reactive; an IgM-negative result several weeks into lymph-node symptoms does not settle the diagnosis.
IgM has a shorter detection window than IgG in many patients, and available assays have variable sensitivity. If testing occurs 4–6 weeks after the first node appeared, the clinician may already have missed the most informative IgM period; a negative result should therefore be interpreted against the entire symptom timeline.
An IgM-positive, IgG-negative pattern may represent very early infection, but nonspecific reactivity is another possibility. Repeating both classes after approximately 10–21 days can look for IgG development, while the examination determines whether waiting is reasonable; an isolated IgM flag should not override an obviously different clinical diagnosis.
Intercurrent viral illness can complicate antibody interpretation, including nonspecific IgM reactions in some assay systems. That does not mean every EBV infection produces a false Bartonella result; rather, fever, sore throat, and generalized nodes should prompt consideration of a second explanation instead of assuming that 1 positive assay answers every question.
The combination of antibody classes matters more than either label alone. Our guide to EBV antibody timing illustrates how 3 markers can separate different stages of one viral infection, while also showing why Bartonella—with a different assay performance profile—requires its own interpretation.
When does repeat Bartonella serology help?
Repeat Bartonella serology is most useful when an early negative, borderline, or isolated IgG result conflicts with a convincing clinical picture. A second specimen approximately 10–21 days later may demonstrate seroconversion or a fourfold rise, providing stronger evidence of recent infection than a single titer.
A fourfold increase means 2 doubling-dilution steps: 1:128 to 1:512, or 1:256 to 1:1024. A rise from 1:128 to 1:256 is only twofold and may be within assay variability; asking the laboratory whether paired specimens can be tested together may improve the comparability of an apparent change.
The retest interval is not identical everywhere. Klotz et al. (2011) suggest repeating uncertain titers after 10–14 days, while laboratories may recommend approximately 2–3 weeks depending on the initial specimen and method; the practical question is whether enough time has passed for a new immune signal to emerge.
Kantesti és una plataforma d’interpretació d’anàlisi de sang AI that can help organize dated reports, but 2 results are not automatically comparable just because they concern the same organism. A change in laboratory, assay, or reporting units can masquerade as a biological trend, which is why we emphasize the original report rather than an isolated screenshot.
Repeat testing is less useful when the first specimen was already collected late and symptoms are steadily resolving. Our explanation of calendari de les analítiques helps distinguish a genuinely evolving result from a stable immune footprint; clinicians should not delay urgent evaluation for 2–3 weeks merely to obtain a cleaner antibody pattern.
When can Bartonella PCR help—and which specimen matters?
Bartonella PCR detects bacterial DNA rather than antibodies and can help when serology is inconclusive or the presentation is atypical. In localized lymph-node disease, an appropriate lymph-node aspirate or tissue specimen may be more informative than peripheral blood; a negative PCR still does not exclude infection.
Bartonella does not have to circulate detectably in peripheral blood while causing a regional node reaction. A blood PCR collected 3 weeks into an otherwise typical localized illness can therefore be negative; the result says more about DNA in that specimen than about every tissue site in the patient.
Hansmann and colleagues evaluated PCR in patients with lymph-node enlargement and showed its diagnostic value alongside other clinical criteria (Hansmann et al., 2005). The study also illustrates why 1 headline sensitivity estimate cannot be transferred to every modern assay: specimen type, case definition, processing, and timing all affect performance.
A node should not be sampled solely because a patient wants a more definitive result. CDC guidance generally reserves aspiration for substantial pain or swelling, or diagnostic uncertainty; if a clinician already plans sampling, discussing PCR and other investigations before the procedure can prevent the only suitable specimen from being handled incorrectly.
Laboratories may need different containers for microbiology, molecular testing, and tissue examination. Our guide to antibodies versus PCR timing explains the wider distinction between an immune footprint and direct organism detection, but each infection requires its own specimen rules—especially when only 1 sample is available.
Can a CBC, CRP, or ESR confirm cat scratch disease?
A CBC, CRP, or ESR cannot confirm cat scratch disease, and normal results do not exclude localized Bartonella infection. These tests help assess the wider illness: a regional node with a normal white-cell count presents a different problem from fever accompanied by abnormalities in 2 or more cell lines.
The white-cell count may remain within the laboratory’s adult reference interval, often approximately 4–11 × 10^9/L, despite a clearly enlarged node. CRP may also be modest or normal in localized disease; neither result measures the probability of Bartonella as directly as the exposure history and regional examination.
Raised inflammatory markers are nonspecific. A CRP of 25 mg/L can accompany several infectious or inflammatory conditions, while an ESR of 50 mm/hour may reflect additional influences such as anemia; our explanation of discrepància entre WBC i CRP helps prevent one normal marker from falsely reassuring the patient.
Reactive lymphocytes may redirect the differential toward a viral illness, although they are not exclusive to viruses. Our guide to troballes de limfòcits reactius explains why morphology and absolute counts matter more than 1 percentage alone, particularly when fatigue and generalized nodes accompany the laboratory flag.
My approach as Thomas Klein, MD, is to ask whether every abnormality fits the proposed diagnosis. If a patient has a solitary tender node but platelets of 80 × 10^9/L and substantial anemia, those additional abnormalities deserve their own evaluation; a positive Bartonella titer should not become a convenient explanation for an entire discordant panel.
What else can cause swollen lymph nodes after cat exposure?
Swollen lymph nodes after cat exposure can still arise from viral infections, ordinary bacterial lymphadenitis, tuberculosis, other animal-associated infections, or malignancy. A positive Bartonella IgG result does not exclude a second diagnosis; progressive enlargement or failure to improve over approximately 4–6 weeks deserves reassessment.
EBV, CMV, acute HIV, and toxoplasmosis can produce overlapping symptoms, particularly when nodes occur in more than 1 region. A sore throat, marked fatigue, splenic enlargement, sexual exposure history, or pregnancy can change which tests are useful; clinicians should choose a targeted differential rather than order every available infection panel.
A negative early Monospot test does not erase the possibility of EBV. Our guide to early Monospot false negatives explains that timing and age affect performance, which matters when 2 incomplete tests—a negative viral screen and a positive low Bartonella titer—appear to point in opposite directions.
Tuberculosis requires a different diagnostic pathway, especially with persistent cervical nodes or relevant epidemiological exposure. Our explanation of IGRA result limitations clarifies why a positive immune test does not establish active nodal tuberculosis and why a negative result cannot reliably exclude every case.
A hard, fixed, supraclavicular, or steadily enlarging node deserves attention even when cat contact is genuine. The 4–6-week reassessment window is a practical follow-up trigger, not permission to wait through rapid deterioration; a node shrinking slowly after typical cat scratch disease may persist for months without implying cancer or treatment failure.
Which symptoms need urgent assessment rather than another titer?
New vision loss, confusion, severe abdominal pain, or serious systemic illness requires prompt assessment, regardless of the Bartonella titer. Cat scratch disease can occasionally involve the eye, nervous system, liver, spleen, bone, or heart; waiting 2–3 weeks for repeat antibodies is inappropriate when those complications are suspected.
A visual complaint is not just another symptom to add to the laboratory request. New blurred vision, a central blind spot, or reduced color perception can require same-day eye assessment; Bartonella-associated neuroretinitis is one possible cause, but clinicians must also evaluate alternatives that need urgent treatment.
Persistent fever with significant abdominal pain may prompt examination and imaging of the liver and spleen. Liver enzymes can be normal or elevated, and 1 abnormal ALT result cannot establish organ involvement; our guide to la interpretació de les proves hepàtiques explains why patterns are more informative than a single flag.
Prolonged fever with a new murmur, embolic features, or a valve history raises a different question: possible endocarditis. Specialist pathways may use high Bartonella IgG thresholds, sometimes around 1:800 in specific criteria, but that context-specific value must not be borrowed as a diagnostic or severity cutoff for uncomplicated cat scratch disease.
Severe illness outranks serology. In an illustrative comparison, a person with IgG 1:1024 and a shrinking node may need routine follow-up, whereas someone with IgG 1:128, confusion, and fever needs urgent care; a low titer cannot compensate for a concerning examination.
How does immunosuppression change Bartonella testing?
Immunocompromised patients may develop a weaker antibody response and more disseminated Bartonella disease, so negative serology can be less reassuring. Fever, unusual skin findings, or organ symptoms in someone receiving chemotherapy, transplant medicines, or substantial immune suppression warrants earlier clinician-led evaluation rather than a routine 2–3-week retest alone.
The relevant issue is not simply whether the patient takes any medicine called an immunosuppressant. The drug, dose, treatment duration, underlying condition, and recent immune measurements all affect risk; 1 low-dose agent and intensive multi-drug transplant therapy should not be treated as equivalent exposures.
Bartonella can cause bacillary angiomatosis and other systemic presentations in severely immunocompromised people. These cases may lack the familiar solitary-node story, so tissue examination, PCR, cultures designed for the clinical question, and specialist assessment may carry more weight than 1 negative IgM result.
Total immunoglobulin concentrations and organism-specific antibodies answer different questions. Our discussion of testing frequent infections explains how recurrent illness may justify broader immune evaluation, but a normal total IgG concentration does not guarantee that a particular Bartonella antibody assay will become positive.
Do not stop an immune-suppressing medicine on the basis of an antibody report. A patient with a transplant and fever of 38.3°C needs prompt contact with the transplant or treating team, because medication changes, specimen collection, and treatment decisions must balance the possible infection against the condition the medicine is controlling.
Does a positive Bartonella titer mean antibiotics are needed?
A positive Bartonella titer alone is not an indication for antibiotics. Many uncomplicated cat scratch disease cases improve without antimicrobial treatment over approximately 2–4 months, while significant symptoms, immune suppression, or suspected organ involvement can justify a different clinician-directed treatment plan.
The evidence for uncomplicated-node treatment is narrower than patients often assume. CDC guidance and Klotz et al. (2011) describe azithromycin as an option that can reduce lymph-node volume sooner, but that does not establish that every seropositive patient benefits from treatment or that persistent antibodies require another course.
One commonly used adult regimen is azithromycin 500 mg on day 1 followed by 250 mg daily on days 2–5, when a clinician decides treatment is appropriate. This is not a self-treatment recommendation: children, cardiac rhythm risks, drug interactions, pregnancy, and complicated disease require individualized prescribing, and systemic Bartonella disease may need entirely different regimens.
Medication reconciliation matters before even a short course. People taking warfarin may need closer INR monitoring when antibiotics or acute illness change their response; our guide to antibiòtics i canvis en l'INR explains why a 5-day prescription can have consequences beyond the infection being treated.
Follow-up should measure recovery, not antibody disappearance. A practical plan records fever, function, pain, and whether the node is shrinking over 2–4 weeks; prevention focuses on veterinary flea control, avoiding rough kitten play, and washing affected contact sites rather than testing healthy household members or removing a well-cared-for cat.
What should you bring when reviewing Bartonella results?
Bring the complete laboratory report, exposure history, symptom dates, and any earlier results—not just a positive flag. Two numbers such as 1:128 and 1:512 become useful only when the clinician knows whether they came from comparable assays and whether your symptoms are improving or progressing.
A useful one-page history includes 5 items: likely cat contact, the first skin change, the first enlarged node, the first fever, and any antibiotic start date. Record medicines and immune conditions as well; an approximate timeline is better than false precision, particularly when the contact event was never noticed.
Kantesti és una Eina d’anàlisi d’analítica de sang impulsada per IA that can help explain IgG and IgM terminology from a laboratory PDF or photo without establishing a diagnosis. A missing less-than sign can turn <1:64 into 1:64, so our PDF transcription checks are particularly relevant to antibody reports.
El nostre La guia de tecnologia d’interpretació describes how Kantesti approaches laboratory explanations; that process cannot replace node palpation, an eye examination, or specimen selection. When 2 reports disagree, the useful output is a list of uncertainties and questions for the clinician—not an artificially confident verdict.
Physician involvement should be transparent rather than implied by a badge. Our consell assessor mèdic describes advisory roles, but an individual patient’s diagnosis still belongs to the treating team; ask that team what finding would change the plan and whether reassessment should occur in 48 hours, 2 weeks, or later.
Research references and related laboratory publications
El Bartonella-specific references below support the antibody, PCR, and management discussion; the 2 linked Zenodo publications address other laboratory topics. They should not be treated as Bartonella diagnostic studies, peer-reviewed clinical guidelines, or evidence that an automated report can diagnose cat scratch disease.
CDC clinical guidance describes persistent antibodies, cross-reactivity, and the limitations of molecular testing in localized disease. Klotz et al. (2011) supplies a clinical overview, while Hansmann et al. (2005) examines PCR in lymph-node enlargement; these 3 sources answer different questions and should not be collapsed into one universal test-accuracy claim.
As of October 7, 2026, this article uses those identifiable sources rather than inventing a new 2026 Bartonella guideline. The material does not establish that a named physician has completed a fresh external review; Kantesti’s estàndards clínics i validació page describes the organization’s methodology, not a guarantee that any single titer interpretation is correct.
The first related publication accompanies our kidney ratio interpretation guide. Kidney measurements can become relevant during systemic illness or medication monitoring, but the BUN/creatinine ratio has 0 established roles as a confirmatory cat scratch disease test; its DOI is provided for publication discovery, not to support the Bartonella thresholds above.
The second publication accompanies our complete urinalysis explanation. Urobilinogen likewise cannot confirm Bartonella infection; both formal citations appear below with DOI links and 2 clearly identified scholarly search links, because a search result must not be represented as a verified ResearchGate or Academia.edu publication record.
Preguntes freqüents
Què és una prova positiva de la malaltia per grat de gat?
Una prova positiva de malaltia per gratada de gat sol significar que un laboratori va detectar anticossos contra Bartonella henselae. Alguns esquemes interpretatius consideren que la IgG per sobre de 1:256 dóna més suport a una infecció recent o actual, però els laboratoris utilitzen mètodes i valors de tall diferents. Un sol resultat positiu no pot distingir de manera fiable l'exposició passada de la infecció activa perquè els anticossos poden persistir durant mesos o anys. Els símptomes, els signes limfonodals regionals i, de vegades, la repetició de la serologia o la PCR determinen la seva significació clínica.
Bartonella henselae IgG 1:1024 significa infecció activa?
Un títol d'anticossos IgG de Bartonella henselae de 1:1024 és alt en moltes proves, però no demostra infecció activa ni mesura la gravetat de la malaltia. Un nivell alt d'IgG pot romandre detectable després de la recuperació, especialment quan no hi ha una mostra anterior per comparar. Un augment de 1:256 a 1:1024 en proves comparables és més informatiu que un resultat únic de 1:1024. Les decisions de tractament encara depenen dels símptomes, l'estat immunològic, els resultats de l'exploració i la possible afectació d'òrgans.
Es pot tenir la malaltia de l'esgarrapada de gat amb anticossos IgM negatius contra Bartonella?
Sí, la malaltia per gratada de gat pot ocórrer amb IgM negativa per Bartonella perquè les respostes IgM poden estar absents, ser de curta durada o passar desapercebudes per a l'assaig. Un resultat negatiu 4-6 setmanes després dels primers símptomes pot ser menys informatiu del que els pacients esperen. Els resultats d'IgG, el cronograma d'exposició i la distribució dels ganglis limfàtics encara poden donar suport al diagnòstic. La repetició d'anticossos o una PCR seleccionada adequadament poden ajudar quan les troballes inicials segueixen sent incertes.
Quan s'han de repetir els títols d'anticossos de Bartonella?
Els títols d'anticossos de Bartonella es poden repetir aproximadament 10–21 dies després d'un resultat inicial negatiu, borderline o inconclús quan la sospita clínica continua sent rellevant. Sempre que sigui possible, s'ha d'utilitzar el mateix laboratori i assaig. Un augment de quatre vegades, com de 1:128 a 1:512, proporciona evidències més fortes d'infecció recent que un canvi de dues vegades. La repetició de la serologia no ha de retardar l'avaluació urgent de pèrdua de visió, confusió, dolor abdominal severa o malaltia sistèmica greu.
És la PCR de Bartonella més precisa que les proves d'anticossos?
Bartonella PCR and antibody testing answer different questions, so neither is universally more accurate. PCR detects bacterial DNA, while serology detects the immune response; in localized lymph-node disease, a suitable node specimen may be more informative than peripheral blood. One negative blood PCR cannot exclude cat scratch disease. The decision to obtain node material should have a clinical justification rather than be made solely to replace an uncertain antibody result.
How long can a lymph node stay swollen after cat scratch disease?
A lymph node associated with uncomplicated cat scratch disease can remain enlarged for approximately 2–4 months and sometimes longer. Gradual shrinkage and improving symptoms are more reassuring than the continued presence of a lump alone. Progressive enlargement, a hard or fixed node, a supraclavicular location, or failure to improve over approximately 4–6 weeks warrants reassessment. A positive Bartonella titer does not exclude another cause of lymph-node enlargement.
Obteniu avui una anàlisi de sang amb IA
Uneix-te a més de 2 milions d’usuaris a tot el món que confien en Kantesti per a una anàlisi instantània i precisa de proves de laboratori. Pengeu els vostres resultats d’anàlisi de sang i rebeu una interpretació completa de biomarcadors 15,000+ en segons.
📚 Publicacions de recerca citades
Klein, T., Mitchell, S., & Weber, H. (2026). Explicació de la relació BUN/Creatinina: Guia de proves de funció renal. Kantesti Recerca mèdica amb IA.
Klein, T., Mitchell, S., & Weber, H. (2026). Prova d’urobilinogen a l’orina: guia completa d’analítica d’orina 2026. Kantesti Recerca mèdica amb IA.
📖 Referències mèdiques externes
Centres per al Control i la Prevenció de Malalties (s. d.). Clinical Guidance for Bartonella henselae. CDC Bartonella Clinical Guidance.
Klotz SA, Ianas V, Elliott SP (2011). Cat-scratch Disease. American Family Physician.
Hansmann Y et al. (2005). Diagnosis of Cat Scratch Disease with Detection of Bartonella henselae by PCR: a Study of Patients with Lymph Node Enlargement. Journal of Clinical Microbiology.
⚕️ Avís mèdic
Aquest article és només per a finalitats educatives i no constitueix assessorament mèdic. Consulteu sempre un professional sanitari qualificat per a decisions de diagnòstic i tractament.
Senyals de confiança E-E-A-T
Experiència
Revisió clínica liderada per metges dels fluxos de treball d’interpretació de laboratori.
Experiència
Enfocament en medicina de laboratori sobre com es comporten els biomarcadors en context clínic.
Autoritat
Escrit pel Dr. Thomas Klein amb revisió de la Dra. Sarah Mitchell i el Prof. Dr. Hans Weber.
Fiabilitat
Interpretació basada en l’evidència amb vies de seguiment clares per reduir l’alarma.